Theravance Biopharma (TBPH) Total Debt (2018 - 2022)
Theravance Biopharma (TBPH) reported Total Debt of $396.13 million for Q2 2022, up 3.7% from $382.01 million a year earlier and up 0.8% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Total Debt (2018 - 2022) Analysis & Trends
At the end of FY2021, Theravance Biopharma posted Total Debt of $388.3 million, down 1.0% from FY2020.
- Total Debt has a three-year compound annual growth rate of 19.2% (FY2018 to FY2021).
- By year, Total Debt came in at $392.21 million in FY2020 (+71.2%), $229.15 million in FY2019 (-0.2%) and $229.54 million in FY2018.
- The Q2 2022 figure ranks as the highest quarterly Total Debt in data going back to Q4 2018.
- Year over year, Total Debt gained in seven of the last eight quarters, with growth averaging 18.5%.
- The high point for year-over-year Total Debt in five years was Q4 2020 (growth of 71.2%); the low point was Q4 2021 (a decline of 1.0%).
- Per Business Quant data, the three quarters before Q2 2022 came in at $393.17 million (Q1 2022), $388.3 million (Q4 2021) and $388.1 million (Q3 2021).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 396.13 Mn |
| Mar 31, 2022 | 393.17 Mn |
| Dec 31, 2021 | 388.30 Mn |
| Sep 30, 2021 | 388.10 Mn |
| Jun 30, 2021 | 382.01 Mn |
| Mar 31, 2021 | 386.84 Mn |
| Dec 31, 2020 | 392.21 Mn |
| Sep 30, 2020 | 384.48 Mn |
| Jun 30, 2020 | 375.27 Mn |
| Mar 31, 2020 | 373.85 Mn |
| Dec 31, 2019 | 229.15 Mn |
| Sep 30, 2019 | 230.71 Mn |
| Jun 30, 2019 | 230.06 Mn |
| Mar 31, 2019 | 229.70 Mn |
| Dec 31, 2018 | 229.54 Mn |
API Access
Theravance Biopharma Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();